Lovastatin treatment of hypercholesterolemia in renal transplant recipients

Medicine and Dentistry

• Hypercholesterolemia 100%
• Kidney Graft 100%
• Lovastatin 100%
• Immunosuppressive Treatment 37%
• Azathioprine 25%
• Placebo 25%
• Scanning Electron Microscopy 12%
• Low Drug Dose 12%
• Allograft 12%
• Kidney Function 12%
• Leukocyte 12%
• Neutrophil 12%
• Patient Population 12%
• High Density Lipoprotein Cholesterol 12%
• Triacylglycerol 12%
• Apolipoprotein 12%
• Liver Enzyme 12%
• Bone Marrow Suppression 12%
• Oxidoreductase 12%
• Low Density Lipoprotein Cholesterol 12%
• Creatine Kinase 12%
• HMG-CoA 12%
• Prednisone 12%
• Isoprenaline 12%

Keyphrases

• Hypercholesterolemia 100%
• Renal Transplant Recipients 100%
• Lovastatin 100%
• Immunosuppression 25%
• Placebo 25%
• LDL Cholesterol 25%
• Neutrophils 12%
• Effective Treatment 12%
• Patient Demographics 12%
• Transplantation 12%
• Renal Function 12%
• Graft Function 12%
• Cholesterol 12%
• Immunosuppressive Therapy 12%
• Creatine Phosphokinase 12%
• Serum Triglycerides 12%
• Liver Enzymes 12%
• Safe Treatment 12%
• 3-hydroxy-3-methylglutaryl-coenzyme A 12%
• Reductase Inhibitors 12%
• Bone Marrow Suppression 12%
• Toa 12%
• Serum Apolipoproteins 12%
• Low Dose Prednisone 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Mevinolin 100%
• Hypercholesterolemia 100%
• Placebo 25%
• Azathioprine 25%
• Scanning Electron Microscopy 12%
• Triacylglycerol 12%
• Low Density Lipoprotein Cholesterol 12%
• Oxidoreductase 12%
• Immunosuppressive Agent 12%
• High Density Lipoprotein Cholesterol 12%
• Liver Enzyme 12%
• HMG-CoA 12%
• Prednisone 12%
• Bone Marrow Suppression 12%
• Isoprenaline 12%
• Creatine Kinase 12%
• Apolipoprotein 12%